Table 2 Frequency of metabolic syndrome components among T2DM patients with sex, at UGCSH, June 2017
From: Metabolic syndrome among type 2 diabetic patients in Ethiopia: a cross-sectional study
Metabolic components | Criteria for MetS | N (%) | Male | Female | P value |
|---|---|---|---|---|---|
Abnormal obesity | IDF | 42 (16.4) | 6 (5.3%) | 36 (25.2%) | < 0.0001 |
WHO | 42 (16.4) | 7 (6.2%) | 35 (24.5%) | < 0.0001 | |
Abnormal fasting | IDF | 239 (93.4%) | 104 (92%) | 135 (94.4%) | 0.452 |
NCEP | 236 (92.2%) | 104 (92%) | 132 (92.3%) | 0.936 | |
Abnormal HDL | IDF | 171 (66.8%) | 58 (51.3%) | 113 (79%) | < 0.0001 |
WHO | 86 (33.6%) | 22 (19.5%) | 64 (44.8%) | < 0.0001 | |
NCEP | 172 (67.2%) | 58 (51.3%) | 114 (79.7%) | < 0.0001 | |
Abnormal TG | IDF | 173 (67.6%) | 65 (57.5%) | 108 (75.5%) | < 0.002 |
WHO | 172 (67.2%) | 64 (56.6%) | 108 (75.5%) | < 0.002 | |
NCEP | 176 (68.8%) | 66 (58.4%) | 110 (76.9%) | < 0.002 | |
Abnormal WC | IDF | 158 (61.7%) | 45 (39.8%) | 113 (79.0%) | < 0.0001 |
NCEP | 137 (53.5%) | 24 (21.2%) | 113 (79.0%) | <  0.0001 | |
Abnormal BP | IDF | 110 (43.0%) | 46 (40.7%) | 64 (44.8%) | 0.516 |
WHO | 61 (23.8%) | 26 (23%) | 35 (24.5%) | 0.784 | |
NCEP | 111 (43.4%) | 47 (41.6%) | 64 (44.8%) | 0.612 |